Archive: 09/08/2017

Off-the-shelf T cell therapies for multiple myeloma

Although a source of much hope among 'multiple myeloma' (MM) patients, adoptive T cell therapies are still held back by expensive, lengthy, individual-tailored approaches. However, an EU-funded project is aiming to shake ...

Early drivers of gastric cancer

Gastric cancer – a leading cause of cancer-related deaths worldwide – is commonly diagnosed at a late stage when most patients have a poor prognosis.

page 6 from 9